Early Phase 1 Hepatitis C Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 years or older
- People who are able and willing to give their consent to participate in the local language
- People who have never received treatment for hepatitis C
- People who attend the trial site for a needle or syringe program, or who have injected drugs at some point in their life
Who may not be able to join:
- People who report having severe liver disease (known as decompensated cirrhosis)
- People who are pregnant or breastfeeding
- People who report having other serious health conditions, such as uncontrolled HIV, kidney problems, tuberculosis, or chronic hepatitis B
- People who are unwilling or unable to stop taking certain medications or supplements that are not safe to take alongside the trial treatment
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Margaret Hellard, Burnet
Phone: +61 413 272 698
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The feasibility of implementing a hepatitis C simplified care (Arm 1) and same-day treatment (Arm 2) care models in community and harm reduction settings in the three study countries.; The proportion of participants initiating hepatitis C treatment in simplified care Arm vs same-day treatment Arm.; The proportion of participants who achieve SVR following hepatitis C treatment in simplified care Arm vs same-day treatment Arm.; The comparative cost and cost-effectiveness of simplified care vs same-day treatment models of care.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.